Abstract
In this issue of Blood , Hirai et al show that proteasome inhibitor bortezomib inhibits survival and function of plasmacytoid dendritic cells.[1][1] Dendritic cells (DCs) are specialized antigen-presenting cells that play a central role in regulation of immunity.[2][2] Their ability to carry out
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
